These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 21872466)

  • 1. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
    Lombardi PM; Cole KE; Dowling DP; Christianson DW
    Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
    Christianson DW
    Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
    Riester D; Wegener D; Hildmann C; Schwienhorst A
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors.
    Wang DF; Wiest O; Helquist P; Lan-Hargest HY; Wiech NL
    J Med Chem; 2004 Jun; 47(13):3409-17. PubMed ID: 15189037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erasers of histone acetylation: the histone deacetylase enzymes.
    Seto E; Yoshida M
    Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a bacterial class 2 histone deacetylase homologue.
    Nielsen TK; Hildmann C; Dickmanns A; Schwienhorst A; Ficner R
    J Mol Biol; 2005 Nov; 354(1):107-20. PubMed ID: 16242151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
    Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
    J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme.
    Moreth K; Riester D; Hildmann C; Hempel R; Wegener D; Schober A; Schwienhorst A
    Biochem J; 2007 Feb; 401(3):659-65. PubMed ID: 17037985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors.
    Su H; Altucci L; You Q
    Mol Cancer Ther; 2008 May; 7(5):1007-12. PubMed ID: 18483291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.
    Finnin MS; Donigian JR; Cohen A; Richon VM; Rifkind RA; Marks PA; Breslow R; Pavletich NP
    Nature; 1999 Sep; 401(6749):188-93. PubMed ID: 10490031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitor.
    Nielsen TK; Hildmann C; Riester D; Wegener D; Schwienhorst A; Ficner R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):270-3. PubMed ID: 17401192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.
    Porter NJ; Christianson DW
    Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the flexibility of human histone deacetylases influences ligand binding: an overview.
    Deschamps N; Simões-Pires CA; Carrupt PA; Nurisso A
    Drug Discov Today; 2015 Jun; 20(6):736-42. PubMed ID: 25597521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylases: structural determinants of inhibitor selectivity.
    Micelli C; Rastelli G
    Drug Discov Today; 2015 Jun; 20(6):718-35. PubMed ID: 25687212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.
    Hodawadekar SC; Marmorstein R
    Oncogene; 2007 Aug; 26(37):5528-40. PubMed ID: 17694092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoform-selective histone deacetylase inhibitors.
    Itoh Y; Suzuki T; Miyata N
    Curr Pharm Des; 2008; 14(6):529-44. PubMed ID: 18336298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.
    Luan Y; Li J; Bernatchez JA; Li R
    J Med Chem; 2019 Apr; 62(7):3171-3183. PubMed ID: 30418766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).
    Luo Y; Li H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Natural Products in Modulating Histone Deacetylases in Cancer.
    Merarchi M; Sethi G; Shanmugam MK; Fan L; Arfuso F; Ahn KS
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30884859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.